Resistance of dialyzed patients to erythropoietin
Rev. bras. hematol. hemoter
;
37(3): 190-197, May-Jun/2015. tab
Article
in English
| LILACS
| ID: lil-752543
ABSTRACT
Resistance to recombinant human erythropoietin is a common condition in dialyzed patients with chronic kidney disease and is associated with more hospitalizations, increased mortality and frequent blood transfusions. The main cause of hyporesponsiveness to recombinant human erythropoietin in these patients is iron deficiency. However, a high proportion of patients does not respond to treatment, even to the use of intravenous iron, which indicates the presence of other important causes of resistance. In addition to the iron deficiency, the most common causes of resistance include inflammation, infection, malnutrition, inadequate dialysis, and hyperparathyroidism, although other factors may be associated. In the presence of adequate iron stores, other causes should be investigated and treated appropriately.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Erythropoietin
/
Renal Dialysis
/
Kidney Transplantation
Limits:
Humans
Language:
English
Journal:
Rev. bras. hematol. hemoter
Journal subject:
Hematology
Year:
2015
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Hospital Felício Rocho/BR
/
Universidade Federal de Minas Gerais/BR
Similar
MEDLINE
...
LILACS
LIS